A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution

Cancer cachexia is a prevalent and often fatal wasting condition that cannot be fully reversed with nutritional interventions. Muscle atrophy is a central component of the syndrome, but the mechanisms whereby cancer leads to skeletal muscle atrophy are not well understood. We performed single-nucleus multi-omics on skeletal muscles from a mouse model of cancer cachexia and profiled the molecular changes in cachexic muscle. Our results revealed the activation of a denervation-dependent gene program that upregulates the transcription factor myogenin. Further studies showed that a myogenin-myostatin pathway promotes muscle atrophy in response to cancer cachexia. Short hairpin RNA inhibition of myogenin or inhibition of myostatin through overexpression of its endogenous inhibitor follistatin prevented cancer cachexia-induced muscle atrophy in mice. Our findings uncover a molecular basis of muscle atrophy associated with cancer cachexia and highlight potential therapeutic targets for this disorder.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2024-08-01
DOI
https://doi.org/10.1016/j.celrep.2024.114587
Citations
18
Primary Topic
Muscle Physiology and Disorders
Type
article
Field-Weighted Citation Impact
4.21

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution

Chunyu Cai, Kenian Chen, Rhonda Bassel‐Duby, Puneeth Iyengar et al.
18 citations
Cell Reports
Muscle Physiology and Disorders
4.21
article

A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution

Chunyu Cai, Kenian Chen, Rhonda Bassel‐Duby, Puneeth Iyengar, Patricio Marcelo Polanco, Rodney E. Infante, Matthieu Dos Santos, Huocong Huang, Karla Cano Hernandez, Eric N. Olson, Rolf A. Brekken, Yichi Zhang, Ning Liu, Lin Xu, Ambar Caijgas
article en
18 citations

Abstract

Cancer cachexia is a prevalent and often fatal wasting condition that cannot be fully reversed with nutritional interventions. Muscle atrophy is a central component of the syndrome, but the mechanisms whereby cancer leads to skeletal muscle atrophy are not well understood. We performed single-nucleus multi-omics on skeletal muscles from a mouse model of cancer cachexia and profiled the molecular changes in cachexic muscle. Our results revealed the activation of a denervation-dependent gene program that upregulates the transcription factor myogenin. Further studies showed that a myogenin-myostatin pathway promotes muscle atrophy in response to cancer cachexia. Short hairpin RNA inhibition of myogenin or inhibition of myostatin through overexpression of its endogenous inhibitor follistatin prevented cancer cachexia-induced muscle atrophy in mice. Our findings uncover a molecular basis of muscle atrophy associated with cancer cachexia and highlight potential therapeutic targets for this disorder.

Cell ReportsVol. 43(8)
Memorial Sloan Kettering Cancer Center (US), Southwestern Medical Center (US), Southwestern Medical Center (US), The University of Texas Southwestern Medical Center (US)
Cancer Prevention and Research Institute of Texas, National Institutes of Health
Zero hunger
Openalex Percentile: Top 5%
Muscle Physiology and Disorders
4.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.